Ebola virus disease: WHO clinical and response update (who.int)

• Licensed monoclonal antibodies only target Zaire ebolavirus.
• No vaccines or therapies for Bundibugyo or other species.
• WHO calls for broad-spectrum medical countermeasures.

"The WHO confirms that licensed monoclonal antibodies exist for Zaire ebolavirus, but no approved vaccines or therapies are available for other species such as Bundibugyo. The update highlights critical gaps in medical countermeasures."